METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTIONS Russian patent published in 2018 - IPC A61K31/4015 A61P25/28 

Abstract RU 2665021 C2

FIELD: medicine.

SUBSTANCE: group of inventions relates to medicine, namely to neurology and psychiatry, and can be used for treating central nervous system (CNS) disorders with cognitive impairment in a subject in need or at risk thereof. Wherein the CNS disorder is an amnestic mild cognitive impairment, dementia, Alzheimer's disease (AD), prodromal AD, post traumatic stress disorder (PTSD), schizophrenia, amyotrphic lateral sclerosis (ALS) and cancer-therapy-related cognitive impairment. Methods for treating, delaying or slowing the progression of central nervous system (CNS) disorders with cognitive impairment, as well as reducing the rate of decline of cognitive function in said condition, comprising the step of administering to said subject a levetiracetam or a pharmaceutically acceptable salt thereof in an amount of 125-250 mg per day. Also provided are pharmaceutical compositions for oral administration once a day for implementing the methods, comprising 125-250 mg of a levetiracetam or a pharmaceutically acceptable salt thereof, wherein a levetiracetam or a pharmaceutically acceptable salt thereof is in a form suitable for sustained release.

EFFECT: group of inventions provides improvement or normalization of cognitive functions in a subject with a CNS disorder, as well as preventing or slowing the progression of said CNS disorder with cognitive impairment.

7 cl, 28 dwg, 6 tbl, 3 ex

Similar patents RU2665021C2

Title Year Author Number
METHODS AND COMPOSITIONS TO IMPROVE COGNITIVE FUNCTIONS 2012
  • Gallagher, Michela
  • Haberman, Rebecca
  • Koh, Ming Teng
RU2792010C2
DERIVATIVES OF AMINOINDAZOLS AND THEIR APPLICATION AS KINASES INHIBITORS 2003
  • Lesjuiss Dominik
  • Djutrju-Rosse Zhill'
  • Allej Frank
  • Babehn Did'E
  • Runi Tomas
  • Tiraboshi Zhill'
RU2339624C2
SUBSTITUTED N-PHENYLPYRROLIDINYL METHYLPYRROLIDINE AMIDES AND THERAPEUTIC USE THEREOF AS MODULATORS OF HISTAMINE H3 RECEPTOR 2008
  • Chekhtizkij Verngard
  • Gao Chzhunli
  • Kherst Uill'Jam Dzh.
  • Shvink Lotar
  • Shtengelin Zigfrid
RU2477721C2
NOVEL AMINOINDAZOLE DERIVATIVES AS MEDICINAL AGENTS AND PHARMECEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES 2003
  • Lesjuiss Dominik
  • Djutrju-Rosse Zhill'
  • Alle Frank
  • Babehn Did'E
  • Runej Tomas
RU2378259C2
17β-HSD1 AND STS INHIBITORS 2006
  • Messinger Jozef
  • Tole Genrikh-Khubert
  • Khuzen Bettina
  • Koskimies Pasi
  • Pirkkala Lila
  • Veske Mikhaehl'
RU2412196C2
AMINOTETRALINE DERIVATIVES CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS AND USING THEM IN THERAPY 2010
  • Amberg Vil'Khel'M
  • Okse Mikhaehl'
  • Lange Udo
  • Kling Andreas
  • Bel' Bertkhol'D
  • Khornberger Vil'Frid
  • Metsler Mario
  • Khatchins Charl'Z
RU2546649C2
HETEROCYCLIC ARYL SULPHONES, SUITABLE FOR TREATING DISORDERS RESPONSIVE TO 5HT RECEPTOR MODULATION 2007
  • Grandel' Roland
  • Braje Vil'Frid Martin
  • Khaupt Andreas
  • Terner Shon Kol'M
  • Lange Udo
  • Dresher Karla
  • Unger Liliane
  • Plata Dehn
RU2451012C2
NOVEL COMPOUNDS AND USE THEREOF IN THERAPY 2004
  • Khirvela Leena
  • Jokhansson Nina
  • Koskimies Pasi
  • Pentikajnen Olli Taneli
  • Nirenen Tommi
  • Salminen Tiina Annamarija
  • Jonson Mark Stuart
  • Lekhtovuori Pekka
RU2412190C2
NEW DERIVATIVES OF HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD FOR MODULATION OF AUTOIMMUNE DISEASES, METHOD FOR PREPARING THESE COMPOUNDS 2000
  • Ehmman'Juehl Mishel' Dzh.
  • Fr'E Lija L.
  • Khikki Judzhin R.
  • Lju Vehjmin'
  • Moruik Tina M.
  • Spero Denis M.
  • Sun' Sansin
  • Tomson Dejvid S.
  • Uord Jansi D.
  • Jang Ehrik R.R.
RU2255937C2
DERIVATIVES OF 2-OXO-1-PYRROLIDINE, METHOD FOR THEIR PREPARING AND USING 2001
  • Differdehn Ehdmon
  • Kenda Benua
  • Ljallemehn Benedikt
  • Matan' Alen
  • Mishel' Filipp
  • Pazo Patrik
  • Talaga Patris
RU2291860C2

RU 2 665 021 C2

Authors

Gallakher Mikhela

Khaberman Rebekka

Kokh Min Ten

Dates

2018-08-24Published

2012-02-09Filed